Skip to main content
Springer Nature Link
Log in

Detecting defects: low initial serum human chorionic gonadotropin (hCG) level may predict future fetal anomalies following frozen embryo transfer (FET)

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To investigate the relationship between early serum hCG levels after frozen embryo transfer and fetal anomalies.

Methods

This was a case–control study at a single academic fertility center between 1/2010 and 12/2021, including all patients who underwent euploid frozen embryo transfers resulting in any fetal anomaly confirmed at the time of induced abortion > 10 weeks or any anomaly reported at delivery. Controls included patients with healthy live births matched for age and day/grade of embryo after euploid FET. The primary outcome was fetal anomaly, with comparisons made using serum hCG levels from cycle day 28 to cycle day 35 and percent change between days 28 and 35.

Results

Both cycle day 28 serum hCG levels and day 35 serum hCG levels were significantly lower in the anomalous group (day 28: 152 vs 177.5 mIU/mL, p < 0.04; day 35: 3033 vs 3744 mIU/mL, p < 0.05). Patients with anomalous outcomes had a significantly lower hCG to start with 5/78 (6.4%) < 50 mIU/mL, 16/78 (20.5%) 51–100 mIU/mL, and 57/78 (73.1%) > 101 mIU/mL, compared to controls 3/78 (3.8%) < 50 mIU/mL, 8/77 (10.3%) 51–100 mIU/mL, and 66/77 (85.7%) > 101 mIU/mL (p < 0.02). However, the rate of rise between day 28 and day 35 was not statistically different (1758.0% vs 2097.0%, p = 0.23).

Conclusion

Patients with anomalous fetal outcomes following frozen embryo transfer had lower early serum hCG levels than controls with healthy live births, highlighting the potential utility of this serum marker to identify high-risk pregnancies in the first trimester and expedite treatment as appropriate for this rare but devastating outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

Data availability

The data that support the findings of this study are available upon request. The data are not publicly available as they contain information that could compromise the privacy of research participants.

References

  1. Ely DM, Driscoll AK. Infant mortality in the United States, 2020: data from the period linked birth/infant death file. Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst. 2022;71:1–18.

    Google Scholar 

  2. Viotti M. Preimplantation genetic testing for chromosomal abnormalities: aneuploidy, mosaicism, and structural rearrangements. Genes. 2020;11:602.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kimelman D, Pavone ME. Non-invasive prenatal testing in the context of IVF and PGT-A. Best Pract Res Clin Obstet Gynaecol. 2021;70:51–62.

    Article  PubMed  Google Scholar 

  4. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics, Committee on Genetics, Society for Maternal-Fetal Medicine. Screening for fetal chromosomal abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020;136:e48-69.

    Article  Google Scholar 

  5. Barnhart KT, Sammel MD, Rinaudo PF, Zhou L, Hummel AC, Guo W. Symptomatic patients with an early viable intrauterine pregnancy: hCG curves redefined. Obstet Gynecol. 2004;104:50–5.

    Article  PubMed  Google Scholar 

  6. Visconti K, Zite N. hCG in ectopic pregnancy. Clin Obstet Gynecol. 2012;55:410–7.

    Article  PubMed  Google Scholar 

  7. Seeber BE. What serial hCG can tell you, and cannot tell you, about an early pregnancy. Fertil Steril. 2012;98:1074–7.

    Article  CAS  PubMed  Google Scholar 

  8. Ryniec J, Esfandiari N. Early serum hCG in IVF: are we trending in the right direction? Reprod Sci Thousand Oaks Calif. 2021;28:1827–38.

    Article  Google Scholar 

  9. Korevaar TIM, Steegers EAP, de Rijke YB, Schalekamp-Timmermans S, Visser WE, Hofman A, et al. Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study. Eur J Epidemiol. 2015;30:1057–66.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sirikunalai P, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes. J Obstet Gynaecol J Inst Obstet Gynaecol. 2016;36:178–82.

    Article  CAS  Google Scholar 

  11. Skogler J, Moberg T, Tancredi L, Styrmisdóttir L, Hedayati E, Alarcon-Ruiz CA, et al. Association between human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes: a systematic review and meta-analysis. Pregnancy Hypertens. 2023;34:124–37.

    Article  PubMed  Google Scholar 

  12. Peris M, Crompton K, Shepherd DA, Amor DJ. The association between human chorionic gonadotropin and adverse pregnancy outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024;230:118–84.

    Article  CAS  PubMed  Google Scholar 

  13. Porat S, Savchev S, Bdolah Y, Hurwitz A, Haimov-Kochman R. Early serum beta-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term pregnancy outcome. Fertil Steril. 2007;88:82–9.

    Article  CAS  PubMed  Google Scholar 

  14. Herkert D, Meljen V, Muasher L, Price TM, Kuller JA, Dotters-Katz S. Human chorionic gonadotropin-A review of the literature. Obstet Gynecol Surv. 2022;77:539–46.

    Article  PubMed  Google Scholar 

  15. Berg JA, Woods NF. Overturning Roe v. Wade: consequences for midlife women’s health and well-being. Womens Midlife Health. 2023;9:2.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Al Mamari N, Al Zawawi N, Khayat S, Badeghiesh A, Son W-Y, Dahan MH. Revisiting serum β-hCG cut-off levels and pregnancy outcomes using single embryo transfer. J Assist Reprod Genet. 2019;36:2307–13.

    Article  PubMed  PubMed Central  Google Scholar 

  17. d’Hauterive SP, Close R, Gridelet V, Mawet M, Nisolle M, Geenen V. Human chorionic gonadotropin and early embryogenesis: review. Int J Mol Sci. 2022;23:1380.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Grin L, Indurski A, Leytes S, Rabinovich M, Friedler S. Trends in primeval β-hCG level increment after fresh and frozen-thawed IVF embryo transfer cycles. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2019;35:261–6.

    Article  CAS  Google Scholar 

  19. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 193: tubal ectopic pregnancy. Obstet Gynecol. 2018;131:e91-103.

    Article  Google Scholar 

  20. Soltes B, Molo MW, Binor Z, Rawlins RG, Radwanska E. Hormonal profiles of early gestations with abnormal karyotype. Fertil Steril. 1993;59:810–4.

    Article  CAS  PubMed  Google Scholar 

  21. Berntsen S, Laivuori H, la CourFreiesleben N, Loft A, Söderström-Anttila V, B Oldereid N, et al. A systematic review and meta-analysis on the association between ICSI and chromosome abnormalities. Hum Reprod Update. 2021;27:801–47.

    Article  CAS  PubMed  Google Scholar 

  22. Zheng Z, Chen L, Yang T, Yu H, Wang H, Qin J. Multiple pregnancies achieved with IVF/ICSI and risk of specific congenital malformations: a meta-analysis of cohort studies. Reprod Biomed Online. 2018;36:472–82.

    Article  PubMed  Google Scholar 

  23. Slade L, Obst K, Deussen A, Dodd J. The tools used to assess psychological symptoms in women and their partners after termination of pregnancy for fetal anomaly: a scoping review. Eur J Obstet Gynecol Reprod Biol. 2023;288:44–8.

    Article  PubMed  Google Scholar 

  24. Davis AR, Horvath SK, Castaño PM. Trends in gestational age at time of surgical abortion for fetal aneuploidy and structural abnormalities. Am J Obstet Gynecol. 2017;216:278.e1-278.e5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. New York University Grossman School of Medicine, 550 1st Avenue, New York, NY, 10016, USA

    Elise Heisler

  2. New York University Langone Fertility Center, NYU Langone Health, 159 East 53rd St, 3rd Floor, New York, NY, 10022, USA

    Emily Weidenbaum & Jennifer K. Blakemore

Authors
  1. Elise Heisler
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Emily Weidenbaum
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Jennifer K. Blakemore
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

All authors contributed to the study conceptualization and design. All authors contributed equally to writing, formal analysis, editing, and approval of the final manuscript.

Corresponding author

Correspondence to Elise Heisler.

Ethics declarations

Ethics approval

This research study was conducted retrospectively from data obtained for clinical purposes.

Consent to participate

Not applicable, as all information is anonymized.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heisler, E., Weidenbaum, E. & Blakemore, J.K. Detecting defects: low initial serum human chorionic gonadotropin (hCG) level may predict future fetal anomalies following frozen embryo transfer (FET). J Assist Reprod Genet 42, 483–488 (2025). https://doi.org/10.1007/s10815-024-03325-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-024-03325-0

Keywords